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Tetraspanins CD9 and CD151 have been implicated in cellular motility and intercellular adhesion in several cellular
types. Here, we have studied the subcellular localization and the functional role of these molecules in primary
melanocytes. We found that endogenous tetraspanins preferentially clustered in areas of melanocyte homotypic
intercellular contacts and at the tips of dendrites. These observations were further conﬁrmed using time-lapse
ﬂuorescence confocal microscopy of melanocytes transfected with CD9– and CD151–GFP (green ﬂuorescent pro-
tein) constructs, suggesting an involvement of these proteins in cellular contacts and migration. Cell adhesion and
migration assays performed using blocking monoclonal antibodies against CD9 and CD151 showed no significant
effect on cell–extracellular matrix adhesion, whereas the migration of melanocytes was significantly enhanced. The
regulation of the migratory capacity of melanocytes by CD9 and CD151 was further conﬁrmed knocking down the
endogenous expression of these tetraspanins with small interference RNA oligonucleotides. Therefore, tetraspanin
molecules are localized at motile structures in primary human melanocytes regulating the migratory capacity of
these cells.
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Tetraspanins comprise a numerous group of proteins that
contain four putative membrane-spanning domains and,
characteristically, the presence of a large divergent extra-
cellular loop between the third and fourth membrane-span-
ning domains (Wright and Tomlinson, 1994). They have been
implicated in the regulation of cell development, prolifera-
tion, activation, and motility and have been shown to couple
to signal transduction pathways (Berditchevski, 2001;
Boucheix and Rubinstein, 2001; Hemler, 2001; Stipp et al,
2003). In this regard, it has been suggested that the main
role of tetraspanins is to organize other proteins into signal-
transducing complexes at the cell surface (Berditchevski,
2001; Ya´n˜ez-Mo´ et al, 2001; Tarrant et al, 2003). Tetraspan-
ins have been shown to coprecipitate with several trans-
membrane proteins, and with b1 integrins in particular
(Berditchevski et al, 1996; Hemler et al, 1996; Rubinstein
et al, 1996; Maecker et al, 1997). In epidermal cell adhesion
and migration, b1 integrins play a critical role (Watt and
Hertle, 1994). To participate in those functions, integrins
may not only bind to intracellular proteins and extracellular
ligands (Clark and Brugge, 1995) but may also laterally
associate with other transmembrane proteins such as
those from the tetraspanin superfamily (Berditchevski, 2001;
Boucheix and Rubinstein, 2001; Hemler, 2001; Stipp et al,
2003).
The migration of melanocytes represents a fundamental
requirement in a wide variety of physiological and patho-
logical scenarios. Melanocytes migrate from the neural
crest to the skin during the first trimester of the embryo-
genesis. In physiological conditions, melanocytes migrate
to display a homogeneous distribution in the epidermis,
which have been designated as an ‘‘epidermal melanin unit’’
(Fitzpatrick and Breathnach, 1963). But insights into the
cellular and molecular mechanisms underlying such organ-
ization, however, remain unknown (Hoath and Leahy, 2003).
In adults, melanocytes also migrate during the process of
wound healing and to cover the white areas of patients with
vitiligo. Although integrins (Morelli et al, 1993) and cadherins
(Hsu et al, 2000) are both implicated in adhesion and move-
ment of melanocytes, little is known about other factors that
regulate both functions. Tetraspanins have been found on
normal epidermis (Okochi et al, 1997; Sincock et al, 1997),
expressed by keratinocytes (Jones et al, 1996; Okochi et al,
1997; Pen˜as et al, 2000). We have previously demonstrated
that tetraspanin molecules have an important role in kera-
tinocyte motility (Pen˜as et al, 2000). On the other hand, CD9
has been functionally associated with tumor cell motility
(Ikeyama et al, 1993) and melanoma invasion (Longo et al,
2001). Nevertheless, no formal study of tetraspanins has
been performed in human primary melanocytes. In this
study, we describe the subcellular localization of CD9 and
CD151 tetraspanin molecules and their functional role in
melanocyte motility.1These authors equally contributed to this work.
Abbreviations: ECM, extracellular matrix; GFP, green fluorescent
protein; mAb, monoclonal antibody; siRNA, small interference RNA
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Results
Melanocytes express CD9 and CD151 tetraspanin pro-
teins at intercellular contacts and tips of dendrites We
analyzed the expression of tetraspanins CD9, CD63, CD81,
and CD151, and integrins avb3, b1, a2, and a3 by flow
cytometry in normal human melanocytes. These primary
cells express high levels of b1 integrin and CD9, and lower
levels of a2 and a3 chains of integrins and tetraspanins
CD81, CD151, and CD63 (Fig 1).
Immunofluorescence studies showed that CD9 and
CD151 are distributed throughout the cell body and the
dendrites of the melanocyte, their clustering at points of
intercellular contact and at the tips of dendrites being re-
markable, where they preferentially colocalized with b1 in-
tegrins (Fig 2a and b). The colocalization percentage
obtained considering the overall surface of the me-
lanocytes, however, is rather average (ranging from 14%
to 28%), and not all contacts and tips contained accumu-
lation of both molecular types (data not shown). CD81 ex-
hibits a staining pattern similar to that of CD9 and CD151,
but no clear CD63 membrane expression was found, al-
though it was highly represented in intracellular vesicles as
it has been found in other cell types such as endothelial
cells and keratinocytes (data not shown) (Ya´n˜ez-Mo´ et al,
1998; Pen˜as et al, 2000).
We found footprints in the immunofluorescence studies
with CD9 but almost no staining with CD151 (data not
shown). These footprints are made of rests of plasma
membrane containing receptors for extracellular matrix pro-
teins that remain attached to the ligands as the cell moves.
We and other authors have described this phenomenon,
also termed ripping, in keratinocytes (Pen˜as et al, 2000) and
other cell types (Palecek et al, 1996).
As these findings suggested an implication of tetraspan-
ins in adhesion to the extracellular matrix, we performed
adhesion experiments on collagen. We used TS2/16 (an
anti-CD29 that activates integrins b1) and VJ1/14 (an anti-
CD29 that inhibits integrins b1) monoclonal antibodies
(mAb) as positive and negative controls of adhesion, re-
spectively. Differences between both TS2/16 (enhancing
adhesion) and VJ1/14 (inhibiting adhesion) were significant
(po0.005) but moderate (  15% from the control). When
melanocytes were incubated with anti-tetraspanin mAb, we
also found a reproducible but very mild modification of ad-
hesion (p15%) compared with control cells without anti-
body treatment, suggesting the lack of implication of CD9
and CD151 in adhesion to collagen (data not shown) as
described for other cell types (Ya´n˜ez-Mo´ et al, 1998).
Tetraspanins CD9 and CD151 are involved in me-
lanocyte–melanocyte interactions To ascertain the kinet-
ics of the localization of tetraspanins in intercellular
homotypic contacts of melanocytes, we erformed time-
lapse fluorescence confocal microscopy with CD9–GFP
(green fluorescent protein) and CD151–GFP-tagged pro-
teins. Using CD9–GFP we found that this molecule showed
a diffuse pattern of accumulation at transient cell–cell con-
tact sites (Fig 3a, Fig S1). CD151–GFP was rapidly and
highly concentrated as soon as dendrites of different me-
lanocytes come into contact (Fig 3b, Fig S2). Both findings
suggest that CD9 and CD151 transiently cluster at the ho-
motypic intercellular contacts during the scanning of the
melanocyte cell surface.
Tetraspanins are implicated in melanocyte motility On
the other hand, another specific area of accumulation was
the tips of the dendrites, which are enriched in ruffles. We
found enhanced expression of CD9–GFP (Fig 4a, Figure S3)
and CD151–GFP (Fig 4b, Fig S4) at the tip of dendrites when
melanocytes explore the surrounding milieu. This localiza-
tion was dynamic and was displayed by all dendrites; those
that directed the movement of the melanocyte and those
that were retracting.
As these results suggested that CD9 and CD151 may be
involved in the movement of melanocytes, they prompted us
to formally explore the functional involvement of tetraspanins
in melanocyte motility using Transwell chambers with fibr-
onectin in the lower chamber as a stimulus for melanocyte
motility. Blocking monoclonal antibodies against CD9 and
CD151, as determined in other cellular types (Ya´n˜ez-Mo´
et al, 1998; Pen˜as et al, 2000), enhanced melanocyte mo-
tility, whereas anti-avb3 integrin inhibited the migration of
melanocytes. The activatory anti-b1 integrin TS2/16 de-
creased the migration of melanocytes, whereas the inhibi-
tory anti-b1 integrin VJ1/14 increased it (Fig 5a). To evaluate
the influence of b1 integrins in CD9 and CD151-mediated
effect on melanocyte migration, we combined the use of
TS2/16 and VJ1/14 with anti-CD9 and anti-CD151 (Fig 5b).
Figure1
Human primary melanocytes express tetraspanins CD9, CD63,
CD81, and CD151. (a) Representative profiles of flow cytometry anal-
ysis corresponding to CD9 and CD151 tetraspanins in melanocytes. (b)
A quantitative analysis of the membrane expression of b1, a2, a3, and
avb3 integrins and CD9, CD63, CD81, and CD151 tetraspanin proteins
expressed as mean fluorescence intensity measured by flow cytometry
(meanþSEM of six to nine experiments). X-63 was used as negative
control.
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We found that the enhanced effect of CD9 and CD151 on
melanocyte migration was more pronounced when com-
bined with VJ1/14, and was partially reversed by TS2/16.
To further assess the functional role of tetraspanins in
melanocyte motility, tetraspanin expression was knocked
down in melanocytes using small interference RNA (siRNA)
against CD9 and CD151. We obtained a significant inhibi-
tion in the expression of CD9 and CD151 using specific
siRNA (Fig 6a), without affecting the morphological charac-
teristics of siRNA-treated melanocytes (data not shown).
We performed similar migration assays using fibronectin as
a stimulus of melanocyte motility with these interfered cells
and found that siRNA against CD9 and CD151 significantly
(po0.05) stimulates melanocyte migration (Fig 6b). Alto-
gether these data underscore the involvement of tetras-
panin in melanocyte migration through regulation of b1
integrin function.
Discussion
The role of tetraspanins in keratinocytes has been explored
previously (Pen˜as et al, 2000). Tetraspanins are implicated in
keratinocyte motility, and a possible implication of these
molecules in inter-keratinocyte contacts has been suggest-
ed. Although CD9, CD81, and CD151 have been described
in melanoma cells (Radford et al, 1996; Longo et al, 2001),
no description of the expression or functional implications
of tetraspanins in normal human melanocytes has been re-
ported before.
This work addresses the expression, subcellular distri-
bution, and functional role in cell adhesion and motility of
the tetraspanins CD9 and CD151 in primary human me-
lanocytes. The accumulation of both tetraspanins at the tips
of the melanocyte dendrites and in the intercellular contacts
with other melanocytes was remarkable. Moreover, some
ripping was found. These findings suggested the involve-
ment of CD9 and CD151 in melanocyte adhesion to the
extracellular matrix, in the exploration of the environment
and in homotypic interactions. CD63, a component of
melanosomes also known as lysosome-associated mem-
brane protein (LAMP)-3, has been described in melanocytes
and melanoma, and implicated in melanoma progression
(Ota et al, 1998). As expected, CD63 showed low plasma
membrane and high intracellular expression in primary me-
lanocytes.
Figure 2
Tetraspanins and b1 integrins colocal-
ize at intercellular contacts of me-
lanocytes and at tips of dendrites. (a)
Representative horizontal confocal sec-
tions showing the subcellular distribution
of CD9 or CD151 (green fluorescence)
compared with b1 integrin (red fluores-
cence), together with the overlay images
are depicted. Scale bar¼ 20 mm. (b) Zoom
images from the representative horizontal
confocal sections shown in the previous
panel are depicted. Co-clustering of tet-
raspanin proteins with b1 integrin at inter-
cellular contacts are indicated with white
arrowheads and at the tips of the dend-
rites are indicated with white arrows.
Scale bar¼ 10 mm.
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The role of tetraspanins in adhesion to the ECM varies
among different cell types, and it has been suggested that
tetraspanins are not involved in cellular adhesion in most
cells (Berditchevski, 2001). In this regard, CD9 did not affect
MDA-MB 231 (Sugiura and Berditchevski, 1999), human B
cells (Shaw et al, 1995) or hepatic cells (Mazzocca et al,
2002) adhesion. Accordingly, our data show that tetraspan-
ins slightly modulate the adhesion of melanocytes to col-
lagen. But CD151 increased adhesion to collagen and
fibronectin of the erytroleukemia cell line HEL (Fitter et al,
1999) but did not affect many other cell lines and human
primary cells (Yauch et al, 1998; Fitter et al, 1999; Sugiura
and Berditchevski, 1999; Mazzocca et al, 2002). It is re-
markable that a defective CD151 protein has been impli-
cated as the cause of epidermolysis bullosa in two patients,
suggesting that this tetraspanin could play a role in kera-
tinocyte adhesion (Karamatic Crew et al, 2004).
Tetraspanins are important in intercellular contacts
(Ya´n˜ez-Mo´ et al, 2001; Tarrant et al, 2003) since they are
clearly accumulated in areas of cell–cell contact in most
cellular types, both in homo- and heterotypic interactions
(Pen˜as et al, 2000; Longo et al, 2001). In fact, the CD151-
a3b1 integrin complex has been shown to regulate cad-
herin-mediated adhesion (Chattopadhyay et al, 2003). We
have found that melanocytes express CD9 and CD151 in
melanocyte–melanocyte contacts and in melanocyte–kera-
tinocyte interactions (unpublished results). Immunofluores-
cence staining of intercellular homotypic interactions was
very conspicuous but not constant, suggesting a dynamic
and transient clustering of the tetraspanins at these sites.
This effect has not been described on keratinocytes or
endothelial cells, where the expression was permanent in
homotypic interactions and absent in cellular areas with
no cell contact. These data, together with the findings of
the time-lapse confocal microscopy with CD9–GFP and
CD151—GFP, suggest that tetraspanins are involved in
some of the phases of the cell–cell contact, perhaps in-
volved in finding the path of other cells.
Regarding the expression of CD9 and CD151 at the tip of
melanocyte dendrites, our findings also suggest a role in the
exploration of the external milieu. On cells of neural origin,
localized expression of tetraspanins CD9 and CD151 on the
tips of the neurites has been implicated in neurite formation
(Smith et al, 1996; Banerjee et al, 1997; Stipp and Hemler,
2000). Our immunofluorescence studies showed that local-
ization of CD9 and CD151 at the tip of melanocyte dendrites
was not permanent, and suggested a dynamic clustering of
both tetraspanins and b1 integrins. The use of GFP-tagged
versions of CD9 and CD151 allowed us to analyze the dy-
namic clustering of these tetraspanins. Although we cannot
exclude that the expression of tetraspanins at the tips of
melanocyte dendrites is related to a role in dendrite forma-
tion, our data on CD9 and CD151 suggest the involvement
of tetraspanins in motility-related structures for the explo-
ration of the environment.
Tetraspanins have been implicated in the motility of many
cell types (Berditchevski, 2001), including melanoma cells
(Longo et al, 2001). The mechanism is still in the process of
being elucidated but, as we have previously described in
keratinocytes, CD9 and CD151 are present at motility-re-
lated structures and not in adhesive contacts to extracel-
lular matrix (Pen˜as et al, 2000). We have found that the anti-
CD9 mAb VJ1/10 enhances the motility of melanocytes in
migration assays and that it is further enhanced with the
anti-b1 integrin VJ1/14. Moreover, CD9 siRNA treatment
enhances the migration of these cells, supporting our find-
ings that CD9 expression is involved in the negative regu-
lation of melanocyte migration. In human melanoma cells
expressing high levels of CD9, anti-CD9 VJ1/10 slightly in-
hibited cell migration, although anti-CD9 VJ1/10 and VJ1/20
Figure 3
CD9—GFP (green fluorescent pro-
tein) and CD151–GFP are dynamical-
ly expressed in intercellular contacts.
Melanocytes transfected with CD9–
GFP or CD151–GFP constructs were
seeded on coverslips and time-lapse
fluorescence confocal microscopy was
started after 4 h. Series of optical sec-
tions distanced 0.4 mm on the z-axis
were acquired every 10 min (CD9) or 15
min (CD151) for a total time of 7 h. a) All
the micrographs depicted show the
transient accumulation of CD9–GFP at
the tip of the dendrite when it contacts
with another untransfected melanocyte
(white arrowheads). A maximum pro-
jection of the relevant sections from the
confocal stack of the GFP and the
merged image also composed with the
corresponding DIC image from each
selected time point of the videose-
quence are shown. Scale bar¼ 10 mm.
(b) The images show the accumulation
of CD151–GFP on the membrane of
the melanocyte as soon as the cell
contacts the dendrite of another highly
transfected melanocyte (T: 00:15, 02:00, 03:00, 03:45, 06:30). When there is no contact, fluorescence intensity returns to basal levels (T: 00:00,
01:30, 04:15). A maximum projection of the relevant sections from the confocal stack of the green signal (GFP) from each corresponding time point
of the videosequence is shown. Scale bar¼20 mm.
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presented a strong inhibitory effect of transendothelial mi-
gration (Longo et al, 2001). Nevertheless, in human and
mouse melanoma cells, low CD9 expression has been re-
lated to enhanced motility, and transfection of mouse me-
lanoma cells with CD9 lowered their metastatic potential
and motility (Ikeyama et al, 1993). It is remarkable that mAb
anti-CD9 inhibited the migration of human keratinocytes
(Pen˜as et al, 2000), endothelial cells (Ya´n˜ez-Mo´ et al, 1998),
and hepatic stellate cells (Mazzocca et al, 2002), whereas it
enhanced the migration of Schwann cells (Anton et al, 1995)
and melanocytes, both of neuroectodermal origin.
On the other hand, the use of anti-CD151 mAb also en-
hances the migration of melanocytes. In contrast, anti-
CD151 mAb inhibited human keratinocyte (Pen˜as et al,
2000), endothelial (Ya´n˜ez-Mo´ et al, 1998), neutrophil (Yauch
et al, 1998), and hepatic stellate cell (Mazzocca et al, 2002)
migration. Our finding that CD151 siRNA treatment also in-
creased the migration of melanocytes supports that the role
Figure 4
CD9–GFP (green fluorescent protein) and CD151–GFP are expressed on the tips of dendrites of melanocytes during cell migration.
Melanocytes transfected with CD9–GFP or CD151–GFP constructs were seeded on coverslips and time-lapse fluorescence confocal microscopy
was started after 4 h. Series of optical sections distanced 0.4 mm on the z-axis were acquired every 15 min (CD9) or 5 min (CD151) for a total time of
7 h. (a) The micrographs show the dynamic accumulation of CD9–GFP at the tips of the dendrite (T: 00:00, T: 01:30, T: 02:30, T: 04:15) during the
exploration of the extracellular environment. A maximum projection of the relevant sections from the confocal stack of the green signal (GFP) from
each corresponding time point of the videosequence is shown. Scale bar¼20 mm. (b) The micrographs show the dynamic accumulation of CD151–
GFP at the tip of the dendrite as the melanocyte migrates on the coverslip. CD151 clusters can be found both on the front (00:30, 01:20, 1:45, 2:10)
and rear (T: 00:05; 00:30, 00:50) dendrites. A maximum projection of the relevant sections from the confocal stack of the green signal (GFP) from
each corresponding time point of the videosequence is shown. Scale bar¼20 mm.
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of CD151 in melanocyte motility is different from what has
been previously described for other cell types.
We have found that tetraspanins modulate migration of
melanocytes. Melanocytes express a2b1, a3b1, a5b1, and
avb3 (Zambruno et al, 1993; Hara et al, 1994). Tetraspanins
have been shown to interact with a2b1 and a3b1 integrins in
many cell types, but not with avb3 (Berditchevski, 2001).
The effect of CD9 and CD151 is partially reverted with TS2/
16 (activating anti-b1 integrin mAb), and it is additive to the
effect of VJ1/14 (inhibitory anti-b1 integrin mAb).
In conclusion, CD9 and CD151 are dynamically clustered
at the tips of dendrites and also in homotypic intercellular
contacts of melanocytes. The inhibition of CD9 and CD151
using mAb or siRNA leads to enhanced motility of the cells.
Nevertheless, CD9 and CD151 do not seem to be involved
in melanocyte adhesion to the extracellular matrix. In ker-
atinocytes, tetraspanins are also involved in motility and are
expressed in intercellular contacts (Pen˜as et al, 2000). It is
therefore tempting to suggest that the expression of tetra-
spanins in cell contacts could be negatively regulating me-
lanocyte migration and, therefore, aiding in the process of
homogeneous redistribution of melanocytes in the normal
epidermis or in the migration of melanocytes to restore the
epidermis damaged during wound healing.
Materials and Methods
Cells Neonatal foreskins obtained within 24 h of elective circum-
cision were used to culture human melanocytes as described pre-
viously (Gilchrest et al, 1984; Park et al, 1993). In brief, epidermal
strips were isolated using dispase 1.2 U per mL (Boehringer Man-
nheim, Mannheim, Germany) for 12 h at 41C. After incubation of
epidermal strips in 0.05% trypsin/0.02% EDTA (Cambrex, Vervies,
Belgiun) for 25 min at room temperature, epidermal cells were
seeded onto plastic dishes (Corning Incorporated, Corning, New
York) at 40,000 cells per cm2. The culture basal medium consisted
in 4:1 Dulbecco’s modified Eagle’s medium (DMEM) with glutamine
and pyruvate (Gibco, Paisley, Scotland, UK) and HAM’S F12 (Gib-
co) complemented with fetal bovine serum 10%, adenine 18 mM
(SIGMA, St Louis, Missouri), hydrocortisone 0.5 mg per mL (SI-
GMA), apo-transferrin 5 mg per mL (SIGMA, Steinheim, Germany),
insulin 5 mg per mL (SIGMA), and choleric toxin 10 ng per mL
(SIGMA). In the first passage, a selective tripsinization was per-
formed and the melanocytes were cultured in a melanocyte-spe-
cific medium: MCDB153 (SIGMA) 5% fetal bovine serum, bovine
Figure 5
Anti-CD9 and -CD151 monoclonal antibodies (mAb) influence me-
lanocyte motility. Melanocyte migration assays were performed in 8-
mm pore Transwell chambers. Fibronectin was added in the lower
chamber as a chemoattractant. The cells that crossed the membrane
were counted. (a) Blocking mAb anti-CD9, anti-CD151, and anti-b1
stimulated the migration of cells, whereas anti-avb3 and activating
anti-b1 inhibited the migration. Results were normalized using as
control mAb-untreated cells as 100%. Results are depicted as the
mean  SEM of seven experiments performed in duplicate. po0.05,
po0.005, and p40.0005 with respect to no mAb treatment. (b)
The same experiment was performed combining the anti-CD9 or anti-
CD151 mAb with the activating anti-b1 or the blocking anti-b1 mAb.
Results were normalized using the control with no mAb treatment as
100% (black line). Results are depicted as the mean  SEM of two
experiments performed in duplicate. po0.05 with respect to no mAb
treatment.
Figure6
Knocking down of CD9 and CD151 expression using small inter-
ference RNA (siRNA) enhances melanocyte motility. (a) Melanocytes
were transfected with CD9 or CD151 siRNA and negatively selected
with anti-CD9 or anti-CD151 magnetic-coated beads, in order to enrich
the tetraspanin low-expressing population. We obtained highly inter-
fered melanocyte cells for each tetraspanin. One representative exper-
iment is shown. The mean inhibition was 49% for CD9 and 56% for
CD151. Dotted line: negative oligo siRNA-transfected melanocytes,
solid line: tetraspanin siRNA-transfected melanocytes, gray area: X-63
used as a negative control of expression. (b) The migratory capacity of
these transfected melanocytes was evaluated using 8-mm pore Tran-
swell chambers. Fibronectin was added in the lower chamber as a
chemoattractant. Negative oligo siRNA-transfected cells were used as
control. Results are shown as the mean  SEM of three experiments
performed in triplicate. po0.05 and po0.005 with respect to neg-
ative oligo siRNA treatment.
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pituitary extract (SIGMA) 30 mg per mL, b-fibroblast growth factor
(SIGMA) 0.6 ng per mL, insulin 5 mg per mL, hydrocortisone 0.5 mg
per mL, and PHA 8 nM (SIGMA). Cultures were used between the
second and fourth passages. Approval was obtained from the
Hospital Universitario de la Princesa institutional review board for
these studies. Informed consent was provided according to the
Declaration of Helsinki.
Antibodies MAb used in this study have been described previous-
ly: the activatory anti-b1 integrin chain TS2/16 (CD29) (Arroyo et al,
1992), the inhibitory anti-b1 integrin VJ1/14 (CD29) (Pen˜as et al,
1998), and the anti-CD151 (LIA1/1 and VJ1/16) (Ya´n˜ez-Mo´
et al, 1998). Anti-CD63 (TEA3/18), anti-CD9 (VJ1/20 and VJ1/10),
anti-a2 (TEA1/41), and anti-a3 (VJ1/6) were obtained in our labo-
ratory (Pen˜as et al, 2000). JS-81 (anti-CD81) was purchased from
BD Biosciences (San Diego, California). The anti-avb3 was a kind
gift from Dr S. Vilaro´ (Department of Cell Biology, Universidad de
Barcelona, Spain). The monoclonal Ig (IgG1, k) from the P3X63
myeloma cell line was used as a negative control, and anti-CD45
antibodies (IgG1, IgG2a, and IgG2b) were used as isotype controls
(Pulido et al, 1988)
Flow cytometry Melanocytes were detached with 0.05% trypsin
and 0.02% EDTA, washed, and resuspended in phosphate-buff-
ered saline (PBS). A total of 5  105 cells were incubated with the
corresponding mAb for 30 min at 41C. After this incubation, cells
were washed in PBS and incubated for 20 min at 41C with the
appropriate fluorescein-isothiocyanate (FITC)-conjugated antibody
(anti-mouse Ig from DAKOPATTS, Copenhagen, Denmark or anti-
rabbit Ig from Pierce Chemical, Rockford, Illinois). Cells were
washed and resuspended in PBS with 10 mg per mL propidium
iodide and then analyzed in a FACScan flow cytometer (Becton
Dickinson Labware, Lincoln Park, New Jersey). Cell analysis was
gated both on forward- and size-scatter intensities and propidium
iodide fluorescence to discard dead cells.
Immunoﬂuorescence and laser scanning confocal micros-
copy Normal human melanocytes were plated in complete
medium on glass coverslips, grown, and fixed in 3.7% parafor-
maldehyde in PBS. Nonspecific binding sites were blocked by in-
cubation with TNB (0.1 M Tris-HCl, 0.15 M NaCl, 0.5% blocking
reagent; Boehringer Mannheim GmbH). Coverslips were incubated
with the primary antibody for 1 h at 371C, washed and incubated
with Rhodamine-X goat anti-mouse IgG secondary antibody (Mo-
lecular Probes, Leiden, The Netherlands) for 45 min. Coverslips
were then blocked with mouse serum, incubated with the corre-
sponding biotinylated antibody for 1 h at 371C, washed, and in-
cubated with Alexa Fluor488-labelled streptavidin (Molecular
Probes, Leiden, The Netherlands) for 45 min. Specimens were
examined with a Leica TCS-SP confocal laser scanning unit
equipped with Ar and He/Ne laser beams and coupled to a Leica
DMIRBE inverted epifluorescence microscope (Leica Microsys-
tems, Heidelberg, Germany), using a  63/1.4 NA oil-immersion
objective. A series of optical sections distanced 0.4 mm on the z-
axis were obtained.
Migration assay Melanocyte migration assays were performed in
8-mm pore Transwell chambers (Corning Incorporated, Corning,
NY). Fibronectin has been described as a stimulus of melanocyte
motility (Zambruno et al, 1993); therefore, fibronectin 10 mg per mL
was added to the lower chamber and incubated for 1 h at 371C.
Melanocytes, resuspended in serum-free medium MCDB153, were
then seeded at 15,000 cells/well on the upper chamber. After
30 min, purified monoclonal antibodies were added to the upper
chamber where appropriate. After 18 h, migrated cells onto the
lower surface of the filter were stained with toluidine blue and
counted. Experiments were carried out in duplicate, and four fields
of each transwell were counted with a  40 objective in an Eclipse
E400 microscope (Nikon, Tokyo, Japan).
Regarding the migration assay using siRNA-transfected
cells, cells were recovered from the lower surface of the filter
by trypsinization after the incubation period for migration,
and the number of migrated cells was estimated by flow
cytometry.
Recombinant DNA constructs, transient transfection, and
time-lapse ﬂuorescence confocal microscopy The CD9–GFP
fusion protein construct was obtained by polymerase chain reac-
tion amplification of the CD9 cDNA (a kind gift from Dr E. Rubin-
stein, INSERM, Villejuif Cedex, France) and cloned in pEGFP-N1
Vector (Clontech Laboratories, Palo Alto, California) in EcoRI sites
of the cloning site, as described elsewhere (Longo et al, 2001). The
CD151–GFP fusion protein construct was also obtained by po-
lymerase chain reaction amplification of the CD151 cDNA (a kind
gift from Dr S. Fujita, Ehime University, School of Medicine, Shige-
nobu, Japan) and cloned in pEGFP-N1 Vector (Clontech Labora-
tories) in HindIII–Kpn1 sites of the cloning site (Barreiro et al,
2005).
Primary melanocytes were trypsinized and resuspended in
MCDB 153 medium supplemented with 5% FCS, 37.5 mM NaCl,
and 20 mg of the vector coding for CD9– or CD151–GFP-tagged
proteins. Cells were transfected by electroporation at 975 mF and
200 V in a Gene Pulser II (Bio-Rad, Hercules, California) and were
allowed to grow up to 24–48 h after transfection. Then, cells were
trypsinized and seeded onto an uncoated 25 mm glass coverslip.
Finally, time-lapse videomicroscopy experiments were performed
after 4 h of cell adhesion. Samples were maintained at 371C in a
5% CO2 atmosphere using an incubation system (La-con GBr Pe-
con GmbH, Erbach, Germany) coupled to the Leica TCS-SP con-
focal laser scanning unit. A series of optical sections distanced
0,4 mm on the z-axis were acquired every 5–15 min during a total
experimental time of 7 h. Green fluorescence and DIC images were
simultaneously obtained using a  63/1.4 NA oil-immersion ob-
jective. Images were processed and assembled into movies using
the Leica Confocal Software.
siRNA assay To knock down the expression of CD9 and CD151
selectively, the silencing sequences described previously (Barreiro
et al, 2005) were used. RNA duplexes corresponding to CD9 and
CD151 target sequences, as well as a negative oligonucleotide
that does not pair with any human mRNA were produced by
Eurogentec (Seraing, Belgium). Oligonucleotides were transfected
in primary melanocytes with oligofectamine (Invitrogen, Carlsbad,
California) following the manufacturer’s instructions. For CD9 in-
terference, melanocytes were transfected on day 0, split on day 2,
and retransfected on day 3. For CD151, cells were transfected only
once on day 3. Then, cells were trypsinized on day 6 and negatively
selected with anti-CD9 or anti-CD151 magnetic-coated beads
(Dynabeads M450 Goat anti-Mouse IgG, Dynal Biotech ASA, Oslo,
Norway), in order to enrich the tetraspanin low-expressing popu-
lation. Cells thus selected were counted and seeded for the dif-
ferent experiments.
Statistical analysis Data were compared using the Student’s t
test or one-way analysis of variance.
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Supplementary Material
The following material is available online for this article.
Figure S1. Video S1 (from Fig 3a). Primary human melanocytes
transiently transfected with CD9-GFP were seeded on a coverslip
for 4 h.
Figure S2. Video S1 (from Fig 3b). Primary human melanocytes
transiently transfected with CD151-GFP were seeded on a coverslip
for 4 h.
Figure S3. Video S1 (from Fig 4a). Primary human melanocytes
transiently transfected with CD9-GFP were seeded on a coverslip
for 4 h.
Figure S4. Video S1 (from Fig 4b). Primary human melanocytes
transiently transfected with CD151-GFP were seeded on a coverslip
for 4 h.
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